Gene · 8202
NCOA3: nuclear receptor coactivator 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. NCOA3: nuclear receptor coactivator 3. Genes, record 8202. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/8202
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9Y6Q9 | Nuclear receptor coactivator 3 | 1,424 | 6 | Ensembl, GeneID, HGNC |
Source UniProt
Patents28
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| WO 2026015647 A1 | 2026-01-15 | 203 | Q9Y6Q9 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 56101 | Q9Y6Q9 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 9307 | Q9Y6Q9 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15345 | Q9Y6Q9 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 9307 | Q9Y6Q9 | Espacenet |
| WO 2025059073 A1 | 2025-03-20 | 236 | Q9Y6Q9 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15345 | Q9Y6Q9 | Espacenet |
| WO 2025038494 A1 | 2025-02-20 | 139 | Q9Y6Q9 | Espacenet |
| WO 2025029835 A1 | 2025-02-06 | 223 | Q9Y6Q9 | Espacenet |
| WO 2025029840 A1 | 2025-02-06 | 535 | Q9Y6Q9 | Espacenet |
1 to 10 of 28
See all 28 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,249
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NCOA3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 59 | 2025 |
| R01HD007857 | Sex Hormone Receptor Component And The Cell Genome | 58 | 2025 |
| R01HD008188 | Reproductive Hormones - Biological and Molecular Actions | 54 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 29 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 26 | 2025 |
| P30CA051008 | Georgetown University Lombardi Comprehensive Cancer Center Support Grant | 26 | 2025 |
| T32CA009686 | Training Grant In Tumor Biology | 20 | 2025 |
| P30DK056338 | Texas Medical Center Digestive Diseases Center | 14 | 2025 |
| P30CA016056 | Roswell Park Cancer Center Support Grant | 9 | 2025 |
| P30CA054174 | Mays Cancer Center at UT Health SA | 9 | 2025 |
1 to 10 of 2,249Source NIH's project files
See all 2,249 nih grantsPapers3,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NRF2-Regulated Ferroptosis in Breast Cancer: Mechanisms, Resistance, and Therapeutic Opportunities. | Asia Pac J Clin Oncol | 2026 | 42802387 | PubTator, text mining | PubMed |
| LSD1 Promotes Immune Exclusion and Suppresses IFN-γ-Associated Transcriptional Programs in Triple-Negative Breast Cancer. | Cancers (Basel) | 2026 | 42794887 | PubTator, text mining | PubMed |
| Systems biology integration of miR-mRNA profiles identifies steroid refractoriness mechanisms and biomarker candidates in ulcerative colitis. | Biochem Biophys Rep | 2026 | 42597943 | PubTator, text mining | PubMed |
| Comparative Genomics Provides Insights into the Evolutionary Origin and Structural Diversification of Steroid Receptor Coactivators (SRCs 1-3). | Molecules | 2026 | 42588544 | PubTator, text mining | PubMed |
| Integrated profiling identifies NCOA3 as a prognostic factor in patients with glioma. | Funct Integr Genomics | 2026 | 42587220 | PubTator, text mining | PubMed |
| Clinical translation of epigenome editing technologies. | Curr Opin Biomed Eng | 2026 | 42582990 | PubTator, text mining | PubMed |
| Yorkie/YAP Interactors: Fine-Tuning the Hippo Pathway Output. | Cold Spring Harb Perspect Biol | 2026 | 42575696 | PubTator, text mining | PubMed |
| Toxic mechanisms and biomarkers of Staphylococcus aureus aerosol exposure to human respiratory cells at the air-liquid interface. | Environ Pollut | 2026 | 42457013 | PubTator, text mining | PubMed |
| Estrogen-related receptor γ functions as a novel corepressor of androgen receptor by destabilizing receptor conformation and blocking coactivator recruitment. | J Biochem | 2026 | 42383774 | PubTator, text mining | PubMed |
| Prostate Cancer: Etiology, Diagnosis, and Treatment. | Serican J Med | 2026 | 42375929 | PubTator, text mining | PubMed |
1 to 10 of 3,524
See all 3,524 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/8202
GET https://conductscience.org/api/genes/v1/8202/patents?page=2